#MSF Access Campaign sur Twitter : “#Big_pharma uses undisclosed ? research and development costs to justify sky-high prices for medicines. Why do these countries ?? ?? ?? ?? ?? ?? want pharma corporations to keep these costs a secret? #TransparencyResolution #WHA72 #NoMoreSecrets” / Twitter
▻https://twitter.com/MSF_access/status/1132899344665993216
Marche arrière toute:
WHO agrees watered-down resolution on transparency in drug costs - Reuters
▻https://www.reuters.com/article/us-health-pricing-idUSKCN1SY0W4
Et un Big prix Pinocchio à Big pharma:
Drug companies argue that cost information is a commercial secret. They say new drugs should be priced according to the benefits they bring to patients, regardless of production and development costs, to ensure companies have a commercial incentive to tackle disease.
Medicine price transparency is a sticky issue at WHA | Health-e
▻https://www.health-e.org.za/2019/05/27/medicine-price-transparency-is-a-sticky-issue-at-wha
Gaelle Krikorian, MSF Access Campaign Head of Policy, blamed “a small minority of wealthy countries” including “Germany, the United Kingdom, Switzerland, the United States, and Japan” for “working to weaken or block the resolution despite the challenges that exist with high prices in their own countries”.